With an extension round of twelve million euros (13 million dollars), Deepc is closing its Series A. Sofinnova Partners and Bertelsmann Investments led the funding round. In addition to existing investor Winning Mindset Ventures, new investors KHP Ventures and Swiss Health Ventures also participated. The startup is using the fresh capital to accelerate its growth and international expansion and improve its operating system. Key growth priorities include expanding presence in the United States, expansion into the UK, and doubling engagement in key European markets.
Franz Pfister, CEO and co-founder of Deepc, explains:
“At Deepc, we believe that the potential of AI in healthcare can only be fully realized if we can close the gap between cutting-edge AI and clinical practice. Our platform makes it easy for organizations to deploy the best AI technologies quickly and at scale to enable faster and more accurate diagnoses and ultimately improve patient outcomes. We are delighted to welcome Swiss Health Ventures and KHP Ventures alongside our existing investors Sofinnova Partners, Bertelsmann Investments, and Winning Mindset Ventures. Together, they bring tremendous strategic value to Deepc and will be a tremendous asset as we continue to scale internationally and further invest in our platform.”
Deepc’s operating system supports the daily work of radiologists. The company’s platform solution provides physicians with access to AI solutions for radiology, enabling more accurate diagnoses and treatment decisions. According to the company, DeepOS is already in use at numerous renowned facilities. These include Solothurn Hospital in Switzerland, the Vivantes Clinic Group and LMU University Hospital in Germany, and the National Health Service in England.
Simon Turner, Partner at Sofinnova Partners, says:
“The influx of capital into AI underscores the importance of foundational technologies that drive adoption in healthcare. These foundational technologies are at the heart of Sofinnova’s digital medicine strategy and are an area that few have mastered so far. From the start, we recognized Deepc’s potential to revolutionize the use of AI in healthcare. This conviction is reinforced today by the support of our new investors, who bring a wealth of expertise to further accelerate the company’s growth.”
